Select Publications
Journal articles
2006, 'Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men - a randomized, placebo-controlled study', AIDS, 20, pp. 1003 - 1010
,2006, 'Evaluation of pituitary function in the fatigued patient: a review of 59 cases', European Journal of Endocrinology, 154, pp. 147 - 157
,2006, 'Hypercarotenaemia', Internal Medicine Journal, 36, pp. 534 - 534
,2006, 'Insulin levels in insulin resistance: phantom of the metabolic opera?', Medical Journal of Australia, 185, pp. 159 - 161
,2006, 'Suppression of HPA axis in adults taking inhaled corticosteroids', Thorax, 61, pp. 272 - 273
,2005, 'Beneficial postprandial effect of a small amount of alcohol on diabetesand cardiovascular risk factors: Modification by insulin resistance', Journal of Clinical Endocrinology and Metabolism, 90, pp. 661 - 672
,2005, 'Changes in body composition and cardiovascular measures in hypercholesterolaemic HIV-infected men treated with pravastatin: a randomized, placebo-controlled study', Antiviral Therapy, 10, pp. L15 - L16
,2005, 'Heritability of body fat using DXA', Obesity Research, 13, pp. 2210 - 2210
,2005, 'Iatrogenic Cushing`s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: Six cases', Journal of Clinical Endocrinology and Metabolism, 90, pp. 4394 - 4398
,2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA', Journal of Infectious Diseases, 191, pp. 1686 - 1696
,2005, 'Insulin resistance: More important to identify than quantify', Nephrology, 10, pp. 597 - 598
,2004, 'Changes in nuclear gene expression resulting from NRTI-induced inhibition of mitochondrial transcription reveal links between mitochondrial dysfunction and lipid metabolism', Antiviral Therapy, 9, pp. L56 - L56
,2004, 'Do gene-environment interactions influence fasting plasma lipids? Astudy of twins', European Journal of Clinical Investigation, 34, pp. 590 - 598
,2004, 'In vivo nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes independent to HIV infection', Antiviral Therapy, 9, pp. L11 - L11
,2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy:randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438, http://dx.doi.org/10.1016/S0140-6736(04)15489-5
,2004, 'Nucleoside reverse transcriptase inhibitors (NRTI) decrease adipocyte and monocyte mitochondrial (mt) messenger RNA transcription in the absence of changes in mtDNA or cell morphology', Antiviral Therapy, 9, pp. L56 - L57
,2004, 'Obesity is an important determinant of baseline serum C-reactiveprotein concentration in monozygotic twins, independent of geneticinfluences', Circulation, 109, pp. 3022 - 3028
,2003, 'Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: Is abdominal adiposity the mediator?', Diabetes Care, 26, pp. 2734 - 2740, http://dx.doi.org/10.2337/diacare.26.10.2734
,2003, 'Type 1 diabetes is not associated with increased central abdominal obesity - Response to Sobel', DIABETES CARE, 26, pp. 2703 - 2703, http://dx.doi.org/10.2337/diacare.26.9.2703
,2003, 'BMI inaccurately reflects total body and abdominal fat in Tongans', ACTA Diabetologica, 40, pp. 282 - 285
,2003, 'Moderate Alcohol Consumption and oestrogen replacement are associated with insulin sensitivity: is lower abdominal adiposity the mediator?', Diabetes Care, 26, pp. 2734 - 2740
,2003, 'Moderate Alcohol Consumption, Dietary Fat Composition, and Abdominal Obesity in Women: Evidence of Gene-Environment Interaction', Journal of Clinical Endocrinology and Metabolism, 88, pp. 5381 - 5386
,2003, 'Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: a study of female twins', Journal of the American College of Cardiology, 42, pp. 264 - 270
,2003, 'Type I diabetes is not associated with increased central abdominal obesity', Diabetes Care, 26, pp. 2703 - 2703
,2002, 'Obesity: Managing the newest epidemic', Current Therapeutics, 43-44, pp. 7 - 11
,2002, 'Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus', Journal of Clinical Endocrinology and Metabolism, 87, pp. 1036 - 1040, http://dx.doi.org/10.1210/jcem.87.3.8324
,2002, 'Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography', Obesity Research, 10, pp. 260 - 265, http://dx.doi.org/10.1038/oby.2002.35
,2002, 'Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy', Diabetes, 51, pp. 3163 - 3169
,2002, 'Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus.', J Clin Endocrinol Metab, 87, pp. 1036 - 1040, http://dx.doi.org/10.1210/jcem.87.3.8324
,2001, 'Anti-retroviral therapy, insulin resistance and lipodystrophy', Diabetes Obesity and Metabolism, pp. 67 - 71
,2001, 'Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women', American Journal of Hypertension, 14, pp. 699 - 703
,2001, 'Lack of heritabiliyt of circulating leptin concentration inhumans after adjustment of body size and adiposity using a physiological approach.', International Journal of Obesity and Related Metabolic Disorders, pp. 1625 - 1632
,2000, 'A physiological model of circulating leptin concentration in humans: Effects of gender, menopause, hormone replacement therapy, and smoking.', DIABETOLOGIA, 43, pp. A173 - A173, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089136700662&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Improved indices of insulin resistance and insulin secretion for use in genetic and population studies of type 2 diabetes mellitus', Twin Research, 3, pp. 148 - 151, http://dx.doi.org/10.1375/136905200320565427
,2000, 'Increasing incidence of type 2 diabetes in the third millennium: Is abdominal fat the central issue?', Diabetes Care, 23, pp. 441 - 442, http://dx.doi.org/10.2337/diacare.23.4.441
,1999, 'Clustering of insulin resistance, total and central abdominal fat: same genes or same environment?', Twin Research, 2, pp. 218 - 225
,1999, 'Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitis: a cohort study', The Lancet, pp. 2093 - 2099
,1999, 'Dietary underreporting is prevalent in middleaged British women and is not related to adiposity (percentage body fat)', International Journal of Obesity and Related Metabolic Disorders, pp. 881 - 888
,1999, 'Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycaemic control, lipid metabolism and vascular factors in Type 2 diabetes: a prospective study', Diabetes Care, pp. 1401 - 1407
,1999, 'Genetic and environmental influences on total-body and central abdominal fat: the effect of physical activity in female twins', Annals of Internal Medicine, 130, pp. 873 - 882
,1999, 'Peripheral lipodystrophy measured by DEXA in patients receiving HIV protease inhibitors', Nuclear Medicine Communications, 20, pp. 390 - 390, http://dx.doi.org/10.1097/00006231-199904000-00104
,1998, 'Reducing misclassification bias in the HOMA indices of insulin resistance and secretion.', DIABETOLOGIA, 41, pp. A109 - A109, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000075353800427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'The effect of estrogen therapy (ET) on central fat, lipids and vascular distensibility in type 2 diabetes', DIABETOLOGIA, 41, pp. A214 - A214, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000075353800830&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Abnormal fat distribution and use of protease inhibitors (multiple letters) [7]', Lancet, 351, pp. 1735 - 1736, http://dx.doi.org/10.1016/s0140-6736(05)77774-6
,1998, 'A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors', AIDS, 12, pp. F51 - F58
,1998, 'Abnormal fat distribution and use of protease inhibitors', Lancet, pp. 1736 - 1736
,1998, 'Can the effectiveness of physical activity programs be improved?', Diabetes Care, 21, pp. 195 - 195
,1998, 'Genes and obesity: mathematics and molecules', ASSO Newsletter Obesity Australasia, pp. 2 - 3
,1998, 'Genes versus environment: The relationship between dietary fat and total and central abdominal fat', Diabetes Care, pp. 2069 - 2076
,1998, 'Obesity: genes, glands or gluttony?', Reproduction Fertility and Development, 10, pp. 49 - 53
,